Search research publications and outputs

  1. 2019
  2. The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy

    Seed, R. I., Taurozzi, A. J., Wilcock, D. J., Nappo, G., Erb, H. H. H., Read, M. L., Gurney, M., Archer, L. K., Ito, S., Rumsby, M. G., Petrie, J. L., Clayton, A., Maitland, N. J. & Collins, A. T., 26 Mar 2019

    Article in Scientific Reports

  3. 2018
  4. 2017
  5. 2016
  6. Cyclin A1 and P450 aromatase promote metastatic homing and growth of stem-like prostate cancer cells in the bone marrow

    Miftakhova, R., Hedblom, A., Semenas, J., Robinson, B. D., Simoulis, A., Malm, J., Rizvanov, A., David Heery, D., Mongan, N. P., Maitland, N. J., Allegrucci, C. & Persson, J. L., 15 Apr 2016

    Article in Cancer research

  7. An epigenetic reprogramming strategy to re-sensitize radioresistant prostate cancer cells

    Peitzsch, C., Cojoc, M., Hein, L., Kurth, I., Mӓbert, K., Trautmann, F., Klink, B., Schrock, E., Wirth, M. P., Krause, M., Stakhovsky, E. A., Telegeev, G. D., Novotny, V., Toma, M. I., Muders, M., Baretton, G. B., Frame, F. M., Maitland, N. J., Baumann, M. & Dubrovska, A., 16 Mar 2016

    Article in Cancer research

  8. 2015
  9. miR-25 modulates invasiveness and dissemination of human prostate cancer cells via regulation of αv- and α6 integrin expression

    Zoni, E., van der Horst, G., van de Merbel, A. F., Chen, L., Rane, J. K., Pelger, R. C. M., Collins, A. T., Visakorpi, T., Snaar-Jagalska, B. E., Maitland, N. J. & van der Pluijm, G., 1 Jun 2015

    Article in Cancer research

  10. CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations

    Khanna, A., Rane, J. K., Kivinummi, K. K., Urbanucci, A., Helenius, M. A., Tolonen, T. T., Saramäki, O. R., Latonen, L., Manni, V., Pimanda, J. E., Maitland, N. J., Westermarck, J. & Visakorpi, T., 19 Apr 2015

    Article in Oncotarget

  11. Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

    Santer, F. R., Erb, H. H. H., Oh, S. J., Handle, F., Feiersinger, G. E., Luef, B., Bu, H., Schäfer, G., Ploner, C., Egger, M., Rane, J. K., Maitland, N. J., Klocker, H., Eder, I. E. & Culig, Z., 20 Mar 2015

    Article in Oncotarget

  12. 2014
  13. 2013
  14. JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells

    Kroon, P., Berry, P. A., Stower, M. J., Rodrigues, G., Mann, V. M., Simms, M., Bhasin, D., Chettiar, S., Li, C., Li, P-K., Maitland, N. J. & Collins, A. T., 3 Jul 2013

    Article in Cancer research

  15. A preclinical xenograft model of prostate cancer using human tumors

    Lawrence, M. G., Taylor, R. A., Toivanen, R., Pedersen, J., Norden, S., Pook, D. W., Frydenberg, M., Papargiris, M. M., Niranjan, B., Richards, M. G., Wang, H., Collins, A. T., Maitland, N. J., Risbridger, G. P. & Australian Prostate Cancer BioResource, 4 Apr 2013

    Article in Nature Protocols

  16. Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells

    Polson, E. S., Lewis, J. L., Celik, H., Mann, V. M., Stower, M. J., Simms, M. S., Rodrigues, G., Collins, A. T. & Maitland, N. J., 27 Mar 2013

    Article in Nature Communications

  17. 2012
  18. Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status (vol 30, pg 1087, 2012)

    Taylor, R. A., Toivanen, R., Frydenberg, M., Pedersen, J., Harewood, L., Collins, A. T., Maitland, N. J., Risbridger, G. P. & Australian Prostate, Aug 2012

    Article in Stem Cells

  19. Human Epithelial Basal Cells Are Cells of Origin of Prostate Cancer, Independent of CD133 Status

    Taylor, R. A., Toivanen, R., Frydenberg, M., Pedersen, J., Harewood, L., Australian Prostate Cancer Bioresource, N. V., Collins, A. T., Maitland, N. J. & Risbridger, G. P., Jun 2012

    Article in Stem cells (Dayton, Ohio)

  20. In Vitro Primary Cell Culture as a Physiologically Relevant Method for Preclinical Testing of Human Oncolytic Adenovirus

    Adamson, R. E., Frazier, A. A., Evans, H., Chambers, K. F., Schenk, E., Essand, M., Birnie, R., Mitry, R. R., Dhawan, A. & Maitland, N. J., 1 Feb 2012

    Article in HUMAN GENE THERAPY

Previous 1 2 3 4 Next